Literature DB >> 20626049

Coping processes and health-related quality of life in Parkinson's disease.

R S Bucks1, K E Cruise, T C Skinner, A M Loftus, R A Barker, M G Thomas.   

Abstract

OBJECTIVE: This study investigated the predictive value of various coping processes for the psychological and disease specific aspects of health-related quality of life (HRQoL) in Parkinson's disease (PD).
METHOD: Cross-sectional study of 85 participants with PD using the Ways of Coping Questionnaire (WCQ), Depression, Anxiety, and Stress Scale (DASS-21), quality of life (PDQ-39), and socio-demographic and clinical variables.
RESULTS: Greater use of planful problem solving coping was found to be significantly associated with better HRQoL in relation to cognitive impairment, communication and bodily discomfort. In addition to greater disease duration, greater use of escape-avoidance coping processes were identified as significant predictors of poorer HRQoL outcomes in the domains of mood and emotional well-being.
CONCLUSION: Psychological interventions such as mindfulness training, aimed at reducing the use of escape-avoidance copying, may help to improve HRQoL in PD.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20626049     DOI: 10.1002/gps.2520

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  16 in total

1.  Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson's disease.

Authors:  Megan K Young; Shu-Kay Ng; George Mellick; Paul A Scuffham
Journal:  Qual Life Res       Date:  2012-07-11       Impact factor: 4.147

2.  Coping Styles in Patients with Parkinson's Disease: Consideration in the Co-Designing of Integrated Care Concepts.

Authors:  Johanne Stümpel; Marlena van Munster; Sylvie Grosjean; David J Pedrosa; Tiago A Mestre
Journal:  J Pers Med       Date:  2022-06-01

3.  Subjective well-being in heart failure patients: influence of coping and depressive symptoms.

Authors:  Ana M Pérez-García; Silvia Oliván; Ramón Bover
Journal:  Int J Behav Med       Date:  2014-04

4.  Dispositional optimism, depression, disability and quality of life in Parkinson's disease.

Authors:  Annalisa Gison; Valentina Dall'Armi; Valentina Donati; Federica Rizza; Salvatore Giaquinto
Journal:  Funct Neurol       Date:  2014 Apr-Jun

5.  Tai Chi Exercise to Improve Non-Motor Symptoms of Parkinson's Disease.

Authors:  Joe R Nocera; Shinichi Amano; Srikant Vallabhajosula; Chris J Hass
Journal:  J Yoga Phys Ther       Date:  2013-08-20

6.  A comparative correlational study of coping strategies and quality of life in patients with chronic heart failure and the general Swedish population.

Authors:  Annika Nilsson; Marianne Carlsson; Ragny Lindqvist; Marja-Leena Kristofferzon
Journal:  Nurs Open       Date:  2017-04-18

7.  Coping mediates the relationship between sense of coherence and mental quality of life in patients with chronic illness: a cross-sectional study.

Authors:  Marja-Leena Kristofferzon; Maria Engström; Annika Nilsson
Journal:  Qual Life Res       Date:  2018-04-05       Impact factor: 4.147

8.  Medication Adherence and Coping with Disease in Patients from a Neurological Clinic: An Observational Study.

Authors:  Gabriele Helga Franke; Julia Nentzl; Melanie Jagla-Franke; Tino Prell
Journal:  Patient Prefer Adherence       Date:  2021-06-28       Impact factor: 2.711

9.  The sense-of-coherence predicts health-related quality of life and emotional distress but not disability in Parkinson's disease.

Authors:  Annalisa Gison; Federica Rizza; Stefano Bonassi; Valentina Dall'Armi; Stefania Lisi; Salvatore Giaquinto
Journal:  BMC Neurol       Date:  2014-10-10       Impact factor: 2.474

Review 10.  A Viewpoint on Wearable Technology-Enabled Measurement of Wellbeing and Health-Related Quality of Life in Parkinson's Disease.

Authors:  Janet M T van Uem; Tom Isaacs; Alan Lewin; Eros Bresolin; Dina Salkovic; Alberto J Espay; Helen Matthews; Walter Maetzler
Journal:  J Parkinsons Dis       Date:  2016-03-10       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.